Andmed seisuga: 27.11.2024 11:40 (GMT+2)
TALLINNA FARMAATSIATEHAS
BALANCE SHEET
BALANCE SHEET, AS AT 31.03.2001
Consolidated/unaudited
in thousand EEK 31.12.2000 31.03.2001
A S S E T S
CURRENT ASSETS
Cash and bank accounts 715 49
Customer receivables
ACCOUNTS RECEIVABLE 4,979 2,079
ALLOWANCE FOR DOUBTFUL RECEIVABLES
RESERVE - -
Total 4,979 2,079
Other receivables
RECEIVABLES FROM PARENT COMPANY 30,375 33,896
OTHER SHORT-TERM RECEIVABLES 98 148
Total 30,473 30,043
Accrued income 37 37
Prepaid expenses 582 595
Inventories
RAW MATERIAL 12,134 10,844
WORK-IN-PROGRESS 565 969
FINISHED GOODS 11,654 15,176
PREPAYMENTS TO SUPPLIERS 1,331 2,113
Total 25,684 29,101
TOTAL CURRENT ASSETS 62,471 65,904
NON-CURRENT ASSETS
Long-term investments 449 449
Fixed assets
FIXED ASSETS IN NET BOOK VALUE 33,636 32,650
CONSTRUCTION IN PROGRESS 119 119
Total 33,755 32,769
Intangible assets 3,216 3,275
TOTAL NON-CURRENT ASSETS 37,420 36,493
TOTAL ASSETS 99,891 102,398
LIABILITIES AND SHAREHOLDERS’ EQUITY
LIABILITIES
CURRENT LIABILITIES
CURRENT PORTION OF LONG-TERM DEBT 7,703 6,372
SHORT-TERM BANK LOANS 496 377
Total 8,200 6,749
Customers prepayments - -
Accounts payable 13,714 14,688
Other payables 3,882 2,944
Taxes payable 701 862
Accrued expenses 2,364 1,913
TOTAL CURRENT LIABILITIES 28,860 27,156
NON-CURRENT LIABILITIES
Long-term debt obligations
BANK LOANS 24,055 24,055
PAYABLES TO PARENT COMPANY 24,351 24,351
TOTAL NON-CURRENT LIABILITIES 48,406 48,406
TOTAL LIABILITIES 77,266 75,562
SHAREHOLDERS’ EQUITY
SHARE CAPITAL 12,500 12,500
RESERVES 2,316 2,316
RETAINED EARNINGS
(ACCUMULATED DEFICIT) -2,779 7,808
PROFIT (LOSS) FOR FINANCIAL YEAR 10,587 4,211
SHAREHOLDERS’ EQUITY TOTAL 22,625 26,836
LIABILITIES AND SHAREHOLDERS’ EQUITY 99,891 102,398
Raivo Unt
Financial Director
+372 612 0201